Select Bibliography

Filter by any of these (after searching):

Clin Cancer Res

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 52 items

A Genome-Wide Association Study Identifies Novel Loci for Paclitaxel-Induced Sensory Peripheral Neuropathy in CALGB 40101

Baldwin, R. Michael , Owzar, Kouros , Zembutsu, Hitoshi ... - - Clin Cancer Res - 2012

Manuscript - Secondary-not-in-original - Primary - PPP - CALGB-40101

Impact of therapy on genomics and transcriptomics in high-risk prostate cancer treated with neoadjuvant docetaxel and androgen deprivation therapy

Beltran, Himisha , Wyatt, Alexander W , Chedgy, Edmund C ... - - Clin Cancer Res - 2017

Manuscript - Secondary-not-in-original - Primary - GU - CALGB-90203

p27Kip1 in Stage III Colon Cancer: Implications for Outcome Following Adjuvant Chemotherapy in CALGB 89803

Bertagnolli, Monica M. , Warren, Robert S. , Niedzwiecki, Donna ... - - Clin Cancer Res - 2009

Manuscript - Secondary - Primary - GI - CALGB-150705 , C89803

Effects of Age and Immune Landscape on Outcome in HER2-positive Breast Cancer in the NCCTG N9831 (Alliance) and NSABP B-31 (NRG) Trials

Chumsri, Saranya , Serie, Daniel J. , Li, Zhuo ... - - Clin Cancer Res - 2019

Manuscript - Secondary-not-in-original - Primary - Breast - N9831 , NSABP B-31

High p95HER2/HER2 Ratio Associated With Poor Outcome in Trastuzumab-Treated HER2-Positive Metastatic Breast Cancer NCCTG N0337 and NCCTG 98-32-52 (Alliance)

Chumsri, Saranya , Sperinde, Jeff , Liu, Heshan , Gligorov, Joseph ... - - Clin Cancer Res - 2018

Manuscript - Secondary-not-in-original - Primary - Correl Sci NOS - N0337 , N98-32-52

Gene Expression Markers of Efficacy and Resistance to Cetuximab Treatment in Metastatic Colorectal Cancer: Results from CALGB 80203 (Alliance)

Cushman, Stephanie M. , Jiang, Chen , Hatch, Ace J. , Shterev, Ivo ... - - Clin Cancer Res - 2015

Manuscript - Secondary - Primary - GI - CALGB-80203

Clinical and Genome Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer

Dolan, M. Eileen , El Charif, Omar , Wheeler, Heather E. ... - - Clin Cancer Res - 2017

Manuscript - Secondary-not-in-original - Primary - PPP - CALGB-90401

Impact of c-MYC Protein Expression on Outcome of Patients with Early-Stage HER2+ Breast Cancer Treated with Adjuvant Trastuzumab NCCTG (Alliance) N9831

Dueck, Amylou C. , Reinholz, Monica M. , Geiger, Xochiquetzal J. ... - - Clin Cancer Res - 2013

Manuscript - Secondary - Primary - Breast - N9831

Prognostic Significance of Defective Mismatch Repair and BRAF-V600E in Patients with Colon Cancer

French, Amy J. , Sargent, Daniel J. , Burgart, Lawrence J. ... - - Clin Cancer Res - 2008

Manuscript - Secondary - Primary - GI - NCCTG-98-46-54

Plasma Insulin-like Growth Factors, Insulin-like Binding Protein-3, and Outcome in Metastatic Colorectal Cancer: Results from Intergroup Trial N9741

Fuchs, Charles S. , Goldberg, Richard M. , Sargent, Daniel J. ... - - Clin Cancer Res - 2008

Manuscript - Secondary - Primary - GI - N9741

Phase II Study of Bevacizumab in Combination with Sorafenib in Recurrent Glioblastoma (N0776): A North Central Cancer Treatment Group Trial

Galanis, E. , Anderson, S. K. , Lafky, J. M. , Uhm, J. , Giannini, C. ... - - Clin Cancer Res - 2013

Manuscript - Primary - Primary - Neuro-Onc - NCCTG-N0776

The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: results from Cancer and Leukemia Group B 9480.

George, Daniel J , Halabi, Susan , Shepard, Timothy F , Sanford, Ben ... - - Clin Cancer Res - 2005

Manuscript - Primary - Primary - GU - INT-0159

CYP2D6 and HOXB13/IL17BR: Combining inherited and tumor gene markers for prediction of tamoxifen resistance

Goetz, Matthew P. , Suman, Vera J. , Couch, Fergus J. ... - - Clin Cancer Res - 2008

Manuscript - Secondary - Primary - PPP - NCCTG-89-30-52

ALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early Stage Non–Small Cell Lung Cancer

Govindan, Ramaswamy , Mandrekar, Sumithra J. , Gerber, David E. ... - - Clin Cancer Res - 2015

Manuscript - No-Endpoint - Trial-Description-Only - Respiratory - A151216

Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism That Increases Risk of Docetaxel-Induced Neuropathy

Hertz, Daniel L. , Owzar, Kouros , Lessans, Sherrie , Wing, Claudia ... - - Clin Cancer Res - 2016

Manuscript - Primary - Primary - PPP - CALGB-60404 , CALGB-90401

A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303

Innocenti, Federico , Owzar, Kouros , Cox, Nancy L. , Evans, Patrick ... - - Clin Cancer Res - 2012

Manuscript - Secondary - Primary - PPP - CALGB-151006 , CALGB-80303

Genomic analysis of germline variation associated with survival of colorectal cancer patients treated with chemotherapy plus biologics in CALGB/SWOG 80405 (Alliance)

Innocenti, Federico , Sibley, Alexander B. , Patil, Sushant A. ... - - Clin Cancer Res - 2021

Manuscript - Secondary - Primary - PPP - CALGB-80405

Tumor Immunogenomic Features Determine Outcomes in Patients with Metastatic Colorectal Cancer Treated with Standard-of-Care Combinations of Bevacizumab and Cetuximab.

Innocenti, Federico , Yazdani, Akram , Rashid, Naim , Qu, Xueping ... - - Clin Cancer Res - 2022

Manuscript - Secondary-not-in-original - Primary - Correl Sci NOS - CALGB-80405

p53 Expression in Node Positive Breast Cancer Patients: Results from the Cancer and Leukemia Group B (CALGB) 9344 Trial (159905)

Lara, Jonathan F. , Thor, Ann D. , Dressler, Lynn G. ... - - Clin Cancer Res - 2011

Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-159905 , CALGB-9344

A comparison of the pharmacokinetics and pharmacodynamics of docetaxel between African-American and Caucasian cancer patients: CALGB 9871.

Lewis, Lionel D , Miller, Antonius A , Rosner, Gary L ... - - Clin Cancer Res - 2007

Manuscript - Primary - Primary - Experimental - CALGB-9871

Identification of a Genomic Region Between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance)

Li, Megan , Mulkey, Flora , Jiang, Chen , O'Neil, Bert H. ... - - Clin Cancer Res - 2018

Manuscript - Secondary-not-in-original - Meta-Analysis - PPP - CALGB-40502 , CALGB-80405 , CALGB-90401 , E5103

Randomized phase II trial and tumor mutational spectrum analysis from cabozantinib versus chemotherapy in metastatic uveal melanoma (Alliance A091201)

Luke, Jason J. , Olson, Daniel J. , Allred, Jacob B. ... - - Clin Cancer Res - 2020

Manuscript - Primary - Primary - Experimental - A091201

Expanded genomic profiling of circulating tumor cells in metastatic breast cancer patients to assess biomarker status and biology over time (CALGB 40502 and CALGB 40503, Alliance)

Magbanua, Mark Jesus M. , Rugo, Hope S. , Wolf, Denise M. ... - - Clin Cancer Res - 2018

Manuscript - Secondary-not-in-original - Meta-Analysis - Correl Sci NOS - CALGB-40502 , CALGB-40503

Clinical significance of circulating tumor cells in hormone receptor-positive metastatic breast cancer patients who received letrozole with or without bevacizumab

Magbanua, Mark Jesus M. , Savenkov, Oleksandr , Asmus, Erik J. ... - - Clin Cancer Res - 2020

Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-40503

A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor positive breast cancer

Nielsen, Torsten O. , Parker, Joel S , Leung, Samuel , Voduc, David ... - - Clin Cancer Res - 2010

Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-159905 , CALGB-9344

Predictive biomarkers of overall survival in patients with advanced renal cell carcinoma treated with interferon alpha +/− bevacizumab: Results from CALGB 90206 (Alliance)

Nixon, Andrew B. , Halabi, Susan , Liu, Yingmiao , Starr, Mark D. ... - - Clin Cancer Res - 2022

Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-90206

Prognostic and Predictive Blood-Based Biomarkers in Patients with Advanced Pancreatic Cancer: Results from CALGB80303 (Alliance)

Nixon, Andrew B. , Pang, Herbert , Starr, Mark D. ... - - Clin Cancer Res - 2013

Manuscript - Secondary - Primary - GI - CALGB-80303

Plasma protein biomarkers in advanced or metastatic colorectal cancer patients receiving chemotherapy with bevacizumab or cetuximab: Results from CALGB 80405 (Alliance)

Nixon, Andrew B. , Sibley, Alexander B. , Liu, Yingmiao ... - - Clin Cancer Res - 2022

Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-80405

KRAS Mutation in Stage III Colon Cancer and Clinical Outcome Following Intergroup Trial CALGB 89803

Ogino, Shuji , Meyerhardt, Jeffrey A. , Irahara, Natsumi ... - - Clin Cancer Res - 2009

Manuscript - Secondary - Primary - GI - CALGB-150705 , CALGB-89803

Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803

Ogino, Shuji , Shima, Kaori , Meyerhardt, Jeffrey A. ... - - Clin Cancer Res - 2012

Manuscript - Secondary - Primary - GI - CALGB-150705 , C89803

Independent validation of the PAM50-based Chemo-Endocrine Score (CES) in hormonal receptor positive HER2-positive breast cancer treated with neoadjuvant anti-HER2-based therapy

Pascual, Tomás , Fernandez-Martinez, Aranzazu , Tanioka, Maki ... - - Clin Cancer Res - 2021

Manuscript - Secondary-not-in-original - Primary - Breast - CALGB-40601

IGF1R Protein Expression is Not Associated with Differential Benefit to Concurrent Trastuzumab in Early-Stage HER2-positive Breast Cancer from the North Central Cancer Treatment Group (Alliance) Adjuvant Trastuzumab Trial N9831

Reinholz, Monica M. , Chen, Beiyun , Dueck, Amylou C. ... - - Clin Cancer Res - 2017

Manuscript - Secondary - Primary - Breast - NCCTG-N9831

Cytokeratin-19 and mammaglobin gene expression in circulating tumor cells from metastatic breast cancer patients enrolled in North Central Cancer Treatment Group (NCCTG) trials, N0234/336/436/437

Reinholz, Monica M. , Kitzmann, Kathleen A. , Tenner, Kathleen ... - - Clin Cancer Res - 2011

Manuscript - Secondary-not-in-original - Primary - Breast - N0234 , N0336 , N0338 , N0436 , N0437

Adrenal androgen levels as predictors of outcome in prostate cancer patients treated with ketoconazole plus antiandrogen withdrawal: results from a cancer and leukemia group B study.

Ryan, Charles J , Halabi, Susan , Ou, San-San , Vogelzang, Nicholas J ... - - Clin Cancer Res - 2007

Manuscript - Secondary-not-in-original - Primary - GU - CALGB-9583

An Interim Analysis Of CALGB 150607: Expression And Mutational Status Of c-MET, HGF, EGFR, KRAS, p53, c-CBL, And E-cadherin In Resected Lung Adenocarcinoma Specimens

Salgia, R. , Nallasura, V. , Pang, H. , Rolle, C. , Richards, W. ... - Chicago MSTO - Clin Cancer Res - 2012

Abstract - Secondary - Preliminary - Correl Sci NOS - CALGB-150607

Combination of temsirolimus (CCI-779) with chemo-radiation in newly diagnosed GBM (NCCTG trial N027D) is associated with increased infectious risks1

Sarkaria, Jann N. , Galanis, Eva , Wu, Wenting , Dietz, Allan B. ... - - Clin Cancer Res - 2010

Manuscript - Primary - Primary - Neuro-Onc - N027D

Association study of the let-7 miRNA-complementary site variant in the 3’ untranslated region of the KRAS gene in stage III colon cancer (NCCTG N0147 clinical trial)

Sha, Dan , Lee, Adam , Shi, Qian , Alberts, Steven R. ... - - Clin Cancer Res - 2014

Manuscript - Secondary-not-in-original - Primary - Correl Sci NOS - N0147

Obesity Is an Independent Prognostic Variable in Colon Cancer Survivors

Sinicrope, Frank A. , Foster, Nathan R. , Sargent, Daniel J. ... - - Clin Cancer Res - 2010

Manuscript - Primary - Primary - GI - N994C

Analysis of Molecular Markers by Anatomic Tumor Site in Stage III Colon Carcinomas from Adjuvant Chemotherapy Trial NCCTG N0147 (Alliance)

Sinicrope, Frank A. , Mahoney, Michelle R. , Yoon, Harry H. ... - - Clin Cancer Res - 2015

Manuscript - Secondary-not-in-original - Primary - Correl Sci NOS - N0147

Prognostic Impact of Bim, Puma, and Noxa Expression in Human Colon Carcinomas

Sinicrope, Frank A. , Rego, Rafaela L. , Okumura, Kenji ... - - Clin Cancer Res - 2008

Manuscript - Secondary - Primary - GI - N0442

Evaluation of sensitivity to endocrine therapy index (SET2,3) for response to neoadjuvant endocrine therapy and longer-term breast cancer patient outcomes (Alliance Z1031)

Suman, Vera J. , Du, Lili , Hoskin, Tanya , Anurag, Meenakshi ... - - Clin Cancer Res - 2022

Manuscript - Secondary-not-in-original - Primary - Correl Sci NOS - A151701 , ACOSOG-Z1031

Integrated analysis of RNA and DNA from the phase III trial CALGB 40601 identifies predictors of response to trastuzumab-based neoadjuvant chemotherapy in HER2-positive breast cancer

Tanioka, Maki , Fan, Cheng , Parker, Joel S , Hoadley, Katherine A ... - - Clin Cancer Res - 2018

Manuscript - Secondary - Primary - Sequencing - CALGB-40601

Mammographic Breast Density Response to Aromatase Inhibition

Vachon, Celine M. , Suman, Vera J. , Brandt, Kathleen R. ... - - Clin Cancer Res - 2013

Manuscript - Primary - Primary - Breast - NCCTG-N063I

Genetic Characterization and Prognostic Relevance of Acquired Uniparental Disomies in Cytogenetically Normal Acute Myeloid Leukemia

Walker, Christopher J. , Kohlschmidt, Jessica , Eisfeld, Ann-Kathrin ... - - Clin Cancer Res - 2019

Manuscript - Secondary-not-in-original - Meta-Analysis - Leuk Corr Sci - C8721 , CALGB-10201 , CALGB-10502 , CALGB-10503 , CALGB-10603 , CALGB-19808 , CALGB-20202 , CALGB-8461 , CALGB-8525 , CALGB-8821 , CALGB-8923 , CALGB-9022 , CALGB-9222 , CALGB-9420 , CALGB-9621 , CALGB-9665 , CALGB-9720

Plasma 25-hydroxyvitamin D levels and survival in stage III colon cancer: Findings from CALGB/SWOG 80702 (Alliance).

Wang, Qiao-Li , Ma, Chao , Yuan, Chen , Shi, Qian , Wolpin, Brian M ... - - Clin Cancer Res - 2023

Manuscript - Secondary - Primary - GI - CALGB-80702

Cholesterol-lowering Intervention Decreases mTOR Complex 2 Signaling and Enhances Antitumor Immunity

Wang, Yanping , You, Sungyong , Su, Shengchen , Yeon, Austin ... - - Clin Cancer Res - 2022

Manuscript - Primary - Primary - Prevention - Pilot

Association of TP53 Mutational Status and Gender with Survival After Adjuvant Treatment for Stage III Colon Cancer: Results of CALGB 89803

Warren, Robert S. , Atreya, Chloe E. , Niedzwiecki, Donna ... - - Clin Cancer Res - 2013

Manuscript - Secondary - Primary - GI - CALGB-89803

Integration of cell line and clinical trial genome-wide analyses supports a polygenic architecture of paclitaxel-induced sensory peripheral neuropathy

Wheeler, Heather E. , Gamazon, Eric R. , Wing, Claudia ... - - Clin Cancer Res - 2013

Manuscript - Secondary-not-in-original - Primary - PPP - CALGB-40101

Molecular analysis of HER2 signaling in human breast cancer by functional protein pathway activation mapping

Wulfkuhle, Julia D. , Berg, Daniela , Wolff, Claudia , Langer, Rupert ... - - Clin Cancer Res - 2012

Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-150007

Inter-tumoral heterogeneity of CD3+ and CD8+ T-cell densities in the microenvironment of DNA mismatch repair-deficient colon cancers: implications for prognosis

Yoon, Harry H. , Shi, Qian , Heying, Erica N. , Muranyi, Andrea ... - - Clin Cancer Res - 2019

Manuscript - Secondary-not-in-original - Primary - Correl Sci NOS - N0147

KRAS codon 12 and 13 mutations in relation to disease-free survival in BRAF-wild type stage III colon cancers from an adjuvant chemotherapy trial (N0147 Alliance)

Yoon, Harry H. , Tougeron, David , Shi, Qian , Alberts, Steven R. ... - - Clin Cancer Res - 2014

Manuscript - Secondary-not-in-original - Primary - Correl Sci NOS - N0147

Plasma 25-Hydroxyvitamin D Levels and Survival in Patients with Advanced or Metastatic Colorectal Cancer: Findings from CALGB/SWOG 80405 (Alliance)

Yuan, Chen , Sato, Kaori , Hollis, Bruce W. , Zhang, Sui ... - - Clin Cancer Res - 2019

Manuscript - Secondary - Primary - GI - CALGB-80405